Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Term ‘White Privilege’ Is ‘Divisive’ and ‘Antagonistic’

Kemi Badenoch, the Conservative Party’s Equalities Minister,…
Read more

Shaping The Next Generation of Muslims

Education is proving to be a controversial issue among Muslim…
Read more

EU Sponsor: Pro-Lifers Are Like Flat Earthers, Abortion a ‘Fundamental Right’

Last Thursday, the European Union parliament passed a resolution…
Read more